Actively Recruiting

Phase 1
Phase 2
Age: 60Years - 80Years
All Genders
Healthy Volunteers
NCT05408559

Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES

Led by Texas Tech University Health Sciences Center · Updated on 2024-11-06

200

Participants Needed

1

Research Sites

212 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Our local IRB approved clinical studies seeking proof of principle for the hypothesis that SFN can be safely administered to humans at doses sufficient to protect age-associated cardiac dysfunctions. Beneficial effects of SFN-therapy will be assessed by Pre- and post-intervention echocardiography, and exercise endurance at 0 and 24 weeks. Peripheral blood cells from treated and control subjects will be compared for mitochondrial respiratory function, oxidative damage, pro-inflammatory cytokines, and expression of antioxidant \& anti-electrophile genes.

CONDITIONS

Official Title

Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES

Who Can Participate

Age: 60Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 60 years
  • Diagnosis of heart failure with preserved ejection fraction (HFpEF) with normal ejection fraction (>=50%)
  • Ability to walk more than 500 feet by self-report
  • Willingness to avoid taking all over-the-counter antioxidant phytochemical supplements during the study
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Diagnosis of active cancer
  • Unable to read and understand the SF-36 questionnaire in English
  • Currently using over-the-counter antioxidant supplements
  • Having pulmonary or other conditions that limit walking ability
  • Receiving oxygen therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Texas Tech University Health Sciences Center (TTUHSC)

Lubbock, Texas, United States, 79430

Actively Recruiting

Loading map...

Research Team

S

Sharda P Singh, PhD

CONTACT

P

Pooja Sethi, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES | DecenTrialz